Vijay K Lathi
CIK 1340806 · last filed 2018-05-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.34M
Companies
6
Total Filings
17
Lifetime Open-Market Net
-$216.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | 10%+ Owner | 384,615 | $0.03 | $11.5K | $17.23M | 1 | 2018-05-31 |
| IRTC | Director | 85,785 | $108.84 | $9.34M | -$80.59M | 10 | 2018-03-12 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2014-11-18 |
| Aravive, Inc. (VSAR) Delisted | 10%+ Owner | 2,559,374 | — | — | -$126.23M | 2 | 2014-11-13 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 1,680,475 | $3.20 | $5.38M | -$27.10M | 1 | 2013-11-25 |
| SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Director | — | — | — | $0 | 1 | 2007-05-17 |
Recent Filings · Page 2 of 2
17 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-25 | IRTC | Mixed | +1,741,589 | $425.0K | EDGAR |
| 2014-11-18 | Durata Therapeutics, Inc. (DRTX) Delisted | Disp (D) | −21,199,073 | $0 | EDGAR |
| 2014-11-13 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −6,400,000 | -$123.97M | EDGAR |
| 2014-10-01 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −113,004 | -$2.26M | EDGAR |
| 2013-11-25 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −3,285,000 | -$27.10M | EDGAR |
| 2011-07-15 | — | Sell (S) | −1,889,577 | -$9.41M | |
| 2007-05-17 | SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.